Group One Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12
| Closed | -$45 | – | 8169 |
|
|
2024
Q3 | $45 | Sell |
12
-2
| -14% | -$11 | ﹤0.01% | 6501 |
|
|
2024
Q2 | $129 | Hold |
14
| – | – | ﹤0.01% | 6543 |
|
|
2024
Q1 | $1.08K | Sell |
14
-57
| -80% | -$7.52K | ﹤0.01% | 6624 |
|
|
2023
Q4 | $12.6K | Sell |
71
-3
| -4% | -$1.48K | ﹤0.01% | 6058 |
|
|
2023
Q3 | $51.9K | Sell |
74
-7
| -9% | -$30K | ﹤0.01% | 5063 |
|
|
2023
Q2 | $373K | Sell |
81
-3
| -4% | -$10.4K | ﹤0.01% | 3314 |
|
|
2023
Q1 | $223K | Sell |
84
-251
| -75% | -$735K | ﹤0.01% | 3562 |
|
|
2022
Q4 | $874K | Sell |
335
-228
| -40% | -$795K | ﹤0.01% | 2538 |
|
|
2022
Q3 | $2.23M | Sell |
563
-41
| -7% | -$161K | ﹤0.01% | 1819 |
|
|
2022
Q2 | $1.58M | Buy |
604
+20
| +3% | +$52.1K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $1.88M | Buy |
584
+331
| +131% | +$1.42M | ﹤0.01% | 2454 |
|
|
2021
Q4 | $1.58M | Buy |
+253
| New | +$1.94M | ﹤0.01% | 2859 |
|
|
2021
Q3 | – | Sell |
-7
| Closed | -$60.2K | – | 8925 |
|
|
2021
Q2 | $75K | Buy |
+7
| New | +$115K | ﹤0.01% | 6227 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 8132 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7119 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6638 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6290 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5856 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5735 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5662 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5489 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5479 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5527 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5699 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5561 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5397 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4763 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4724 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4656 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4524 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4273 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4227 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4236 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4021 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3652 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3859 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4216 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4116 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3352 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 5560 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3341 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 2996 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4538 |
|
Other funds holding SEEL
Group One Trading's SEEL Position: Q4 2024 in Review
Group One Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2024, closing a stake of 12 shares — an estimated $45 sold.
Group One Trading first reported a position in SEEL in Q2 2021 and held it in 13 quarters. The position peaked at $2.23M in Q3 2022. 2 funds tracked by Wall St. Rank hold SEEL as of Q4 2024.
- Group One Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 12 Seelos Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $45.
- Group One Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
- Group One Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $2.23M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.